| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10980221 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 117 journal articles in the PubMed database | Email to a friend | | |
| Kitzman DW, Goldman ME, Gillam LD, et al.
Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Cardiol 2000 Sep 15; 86(6):669-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Grayburn PA, Weiss JL, Hack TC, et al.
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1998 Jul; 32(1):230-6.
Abstract | Full Citation | Find Related Articles | | Cohen JL, Cheirif J, Segar DS, et al.
Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1998 Sep; 32(3):746-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Senior R, Andersson O, Caidahl K, et al.
Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent: A European multicenter study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Echocardiography 2000 Nov; 17(8):705-11.
Abstract | Full Citation | Find Related Articles | | Nanda NC, Kitzman DW, Dittrich HC, et al.
Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Echocardiography 2003 Feb; 20(2):151-61.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Crouse LJ, Cheirif J, Hanly DE, et al.
Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1993 Nov 1; 22(5):1494-500.
Abstract | Full Citation | Find Related Articles | | Hausnerova E, Gottdiener JS, Gould JJ, et al.
Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Soc Echocardiogr 1999 Nov; 12(11):957-66.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nayyar S, Magalski A, Khumri TM, et al.
Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction in patients with left ventricular dysfunction and good baseline endocardial border delineation. [Journal Article]
Am J Cardiol 2006 Oct 15; 98(8):1110-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weissman NJ, Cohen MC, Hack TC, et al.
Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial. [Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am Heart J 2000 Mar; 139(3):399-404.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
